Skip to main content
Human Metabolome Technologies, Inc. logo

Human Metabolome Technologies, Inc. — Investor Relations & Filings

Ticker · 6090 ISIN · JP3794530000 T Professional, scientific and technical activities
Filings indexed 73 across all filing types
Latest filing 2018-11-12 Interim / Quarterly Rep…
Country JP Japan
Listing T 6090

About Human Metabolome Technologies, Inc.

https://humanmetabolome.com/

Human Metabolome Technologies, Inc. is a biotechnology company specializing in metabolomics. As a pioneer and global leader in the field, it leverages proprietary capillary electrophoresis mass spectrometry (CE-MS) based technology for comprehensive metabolome analysis. The company provides a range of analytical services, including global profiling, targeted assays, metabolic flux analysis, and lipidomics. These services support research and development projects, particularly in biomarker discovery and drug development, by delivering high-quality metabolomics data to address complex scientific and medical challenges.

Recent filings

Filing Released Lang Actions
四半期報告書-第16期第2四半期(2018/07/01-2018/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Tohoku Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains detailed financial statements, management analysis, and auditor review information for the second quarter of the fiscal year. This fits the definition of an Interim/Quarterly Report (IR). Q2 2018
2018-11-12 Japanese
四半期報告書-第16期第1四半期(2018/04/01-2018/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the first quarter of the 16th fiscal year, covering the period from April 1, 2018, to June 30, 2018. It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, as well as management analysis and notes. This fits the definition of an Interim/Quarterly Report (IR). Q1 2019
2018-08-13 Japanese
有価証券報告書-第15期(平成29年4月1日-平成30年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, business overviews, and management information for the fiscal year ending March 31, 2018. The document structure, including the cover page with regulatory references (Financial Instruments and Exchange Act Article 24, Paragraph 1) and the inclusion of comprehensive financial tables, confirms it is an annual report. FY 2018
2018-06-26 Japanese
四半期報告書-第15期第3四半期(2017/10/01-2017/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第3四半期報告書) for Human Metabolome Technologies, Inc. It contains detailed financial statements (balance sheet, income statement), management analysis of financial results, and is filed under the Financial Instruments and Exchange Act (金融商品取引法). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-02-13 Japanese
四半期報告書-第15期第2四半期(2017/07/01-2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Human Metabolome Technologies, Inc., covering the second quarter of the 15th fiscal period (April 1, 2017, to September 30, 2017). It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2017
2017-11-13 Japanese
四半期報告書-第15期第1四半期(2017/04/01-2017/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Human Metabolome Technologies, Inc., covering the first quarter of the 15th fiscal period (April 1, 2017 to June 30, 2017). It contains detailed financial statements, including the balance sheet, income statement, and segment information, as required by the Financial Instruments and Exchange Act of Japan. Since it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). Q1 2017
2017-08-14 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.